Alan Colowick Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Alan Colowick.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Alan Colowick. Alan Colowick is Chief Medical Officer in THRESHOLD PHARMACEUTICALS INC ($THLD) and Director in Achaogen Inc ($AKAO) and Director in Principia Biopharma Inc. ($PRNB) and Director in Personalis, Inc. ($PSNL) and Director in Dimension Therapeutics, Inc. ($DMTX) and Director in Harpoon Therapeutics, Inc. ($HARP).
Latest Insider Trading Transactions of Alan Colowick
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKAO, DMTX, HARP, MTEM, PSNL, PRNB
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 07 2021 | HARP | Harpoon Therapeuti ... | Colowick Alan | Director | Option Exercise | A | 22.50 | 10,167 | 228,758 | 10,167 | |
| Mar 26 2021 | HARP | Harpoon Therapeuti ... | Colowick Alan | Director | Option Exercise | A | 19.63 | 20,335 | 399,176 | 20,335 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Colowick Alan | Director | Option Exercise | D | 62.66 | 10,240 | 641,638 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Colowick Alan | Director | Option Exercise | D | 31.77 | 10,240 | 325,325 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Colowick Alan | Director | Option Exercise | D | 17.00 | 20,475 | 348,075 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Colowick Alan | Director | Option Exercise | D | 4.54 | 47,724 | 216,762 | 0 | |
| Jul 02 2020 | PRNB | Principia Biopharm ... | Colowick Alan | Director | Option Exercise | M | 4.54 | 7,500 | 34,065 | 47,724 | |
| Jul 02 2020 | PRNB | Principia Biopharm ... | Colowick Alan | Director | Sell | S | 60.00 | 7,500 | 450,000 | 0 | 7.5 K to 0 (-100.00 %) |
| Jul 02 2020 | PRNB | Principia Biopharm ... | Colowick Alan | Director | Buy | M | 4.54 | 7,500 | 34,065 | 7,500 | 0 to 7.5 K |
| Jun 08 2020 | PRNB | Principia Biopharm ... | Colowick Alan | Director | Option Exercise | A | 62.66 | 10,240 | 641,638 | 10,240 | |
| May 19 2020 | PSNL | Personalis, Inc. | Colowick Alan | Director | Option Exercise | A | 11.22 | 14,000 | 157,080 | 14,000 | |
| May 05 2020 | PRNB | Principia Biopharm ... | Colowick Alan | Director | Option Exercise | M | 4.54 | 6,660 | 30,250 | 55,224 | |
| May 05 2020 | PRNB | Principia Biopharm ... | Colowick Alan | Director | Option Exercise | M | 4.54 | 840 | 3,815 | 61,884 | |
| May 05 2020 | PRNB | Principia Biopharm ... | Colowick Alan | Director | Sell | S | 60.00 | 6,660 | 399,600 | 0 | 6.7 K to 0 (-100.00 %) |
| May 05 2020 | PRNB | Principia Biopharm ... | Colowick Alan | Director | Buy | M | 4.54 | 6,660 | 30,250 | 6,660 | 0 to 6.7 K |
| May 05 2020 | PRNB | Principia Biopharm ... | Colowick Alan | Director | Sell | S | 60.07 | 840 | 50,457 | 0 | 840 to 0 (-100.00 %) |
| May 05 2020 | PRNB | Principia Biopharm ... | Colowick Alan | Director | Buy | M | 4.54 | 840 | 3,815 | 840 | 0 to 840 |
| Jun 11 2019 | PRNB | Principia Biopharm ... | Colowick Alan | Director | Option Exercise | A | 31.77 | 10,240 | 325,325 | 10,240 | |
| Jan 10 2019 | PRNB | Principia Biopharm ... | Colowick Alan | Director | Option Exercise | A | 17.00 | 20,475 | 348,075 | 20,475 | |
| Nov 07 2017 | DMTX | Dimension Therapeu ... | Colowick Alan | Director | Option Exercise | D | 7.08 | 32,069 | 227,049 | 0 | |
| Nov 07 2017 | DMTX | Dimension Therapeu ... | Colowick Alan | Director | Option Exercise | D | 1.15 | 17,000 | 19,550 | 0 | |
| Nov 07 2017 | DMTX | Dimension Therapeu ... | Colowick Alan | Director | Option Exercise | D | 4.85 | 44,474 | 215,699 | 0 | |
| Jun 16 2017 | AKAO | Achaogen Inc | Colowick Alan | Director | Option Exercise | A | 22.11 | 10,000 | 221,100 | 10,000 | |
| May 26 2017 | DMTX | Dimension Therapeu ... | Colowick Alan | Director | Option Exercise | A | 1.15 | 17,000 | 19,550 | 17,000 | |
| Jun 17 2016 | AKAO | Achaogen Inc | Colowick Alan | Director | Option Exercise | A | 4.84 | 10,000 | 48,400 | 10,000 | |
| May 23 2016 | DMTX | Dimension Therapeu ... | Colowick Alan | Director | Option Exercise | A | 7.08 | 32,069 | 227,049 | 32,069 | |
| Mar 13 2015 | AKAO | Achaogen Inc | Colowick Alan | Director | Option Exercise | A | 10.44 | 20,000 | 208,800 | 20,000 | |
| Sep 28 2006 | THLD | THRESHOLD PHARMACE ... | Colowick Alan | Chief Medical Offic ... | Option Exercise | D | 14.51 | 150,000 | 2,176,500 | 0 | |
| Sep 28 2006 | THLD | THRESHOLD PHARMACE ... | Colowick Alan | Chief Medical Offic ... | Option Exercise | A | 2.50 | 150,000 | 375,000 | 150,000 | |
| Mar 15 2006 | THLD | THRESHOLD PHARMACE ... | Colowick Alan | Chief Medical Offic ... | Option Exercise | A | 14.51 | 150,000 | 2,176,500 | 150,000 |
Page: 1